Nurofen superiority claims breached consumer law, Full Court affirms

Competition & Consumer Protection 2018-08-24 11:19 am | Sydney
The Full Federal Court has shot down Reckitt Benckiser’s appeal of a ruling that it misled consumers with claims that its Nurofen is a more effective pain killer than rival GlaxoSmithKline’s Panadol.
For information on rights and reprints, contact subscriptions@lawyerly.com.au